Form D · Other Technology
Mantra Health, Inc.
New York, NY · CIK 0001764746
Offering snapshot reported Feb 28, 2023 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 14, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 28, 2023 | Initial | $4,999,999 | No comparison | 12 | SEC filing |
| Dec 8, 2021 | Initial | $20,000,002 | No comparison | 14 | SEC filing |
| Aug 10, 2021 | Initial | $120,000 | No comparison | Not reported | SEC filing |
| Mar 12, 2021 | Amendment | $2,000,000 | $1,500,000vs Jan 14, 2021 | 16 | SEC filing |
| Jan 14, 2021 | Initial | $500,000 | No comparison | 7 | SEC filing |
| Jan 17, 2019 | Initial | $2,000,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-474412
Source: Form D, filed Feb 28, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cedric Asselman | Director |
| Hugues Braucourt | Director |
| Khira Gabliani | Director |
| Edouard Gaussen | Director, Executive |
| Andrew Hermalyn | Director |
| Matthew Kennedy | Director, Executive |
| Michael Mauze | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
26 Broadway, Suite 318
New York, NY, 10004
New York, NY, 10004